Cúrdia Gonçalves T^1,2,3*, Barbosa M^1,2,3, Monteiro S^1,2,3, Magalhães J^1,2,3, Rosa B1,2,3, Leite S^1,2,3, Cotter J^1,2,3

¹ Department of Gastroenterology, Hospital da Senhora da Oliveira, Guimarães, Portugal

² Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal

³ ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal

ABSTRACT

Dieulafoy’s lesion is an infrequent, but potentially life-threatening, vascular abnormality. Although the conventional hemostatic therapies are generally effective, rebleeding can occur in up to 40% of the cases. We report a case in which rebleeding from a Dieulafoy’s lesion was controlled with the hemostatic powder TC-325.

› Article